|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||31.57 - 32.02|
|52-week range||31.57 - 32.02|
|Beta (5Y monthly)||1.90|
|PE ratio (TTM)||N/A|
|Earnings date||04 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
PacBio's (PACB) latest acquisition is expected to deliver a differentiated set of products and applications across a wide spectrum of markets.
If you're Cathie Wood, founder, and CEO of ARK Invest, you keep buying more. Shares of life-science equipment manufacturer Berkeley Lights (NASDAQ: BLI) took a hit last week, and two ARK Invest ETFs quickly bought more. Wood also bought two genomics stocks that have tanked this year, Personalis (NASDAQ: PSNL) and Invitae (NYSE: NVTA).
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.